27 results on '"Trojan, Lutz"'
Search Results
2. Discriminating malignant and benign clinical T1 renal masses on computed tomography: A pragmatic radiomics and machine learning approach
3. Tumor laterality in renal cancer as a predictor of survival in large patient cohorts: A STROBE compliant study
4. Insulin‐like growth factor 2 expression in prostate cancer is regulated by promoter‐specific methylation
5. See the Unseen: Mesorectal Lymph Node Metastases in Prostate Cancer
6. Testosterone boosts for treatment of castration resistant prostate cancer: An experimental implementation of intermittent androgen deprivation
7. New insights into the influence of cigarette smoking on urothelial carcinogenesis: Smoking-induced gene expression in tumor-free urothelium might discriminate muscle-invasive from nonmuscle-invasive urothelial bladder cancer
8. EXTERNAL VALIDATION OF DISEASE-FREE SURVIVAL AT 2 OR 3 YEARS AS A SURROGATE AND NEW PRIMARY ENDPOINT FOR PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR MUSCLE INVASIVE UROTHELIAL CANCER OF THE BLADDER: 530
9. External Validation of a Risk Model to Predict Recurrence-Free Survival After Radical Cystectomy in Patients With Pathological Tumor Stage T3N0 Urothelial Carcinoma of the Bladder
10. Neuroendocrine tumor cells in prostate cancer: Evaluation of the neurosecretory products serotonin, bombesin, and gastrin – impact on angiogenesis and clinical follow-up
11. Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladder
12. Gastrin-Releasing Peptide: Predictor of Castration-Resistant Prostate Cancer?†
13. Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial
14. Prognostic Factors of Papillary Renal Cell Carcinoma: Results From a Multi-Institutional Series After Pathological Review
15. The role of lymphangiogenesis in lymphatic tumour spread of urological cancers
16. The lymphatic system and its specific growth factor vascular endothelial growth factor C in kidney tissue and in renal cell carcinoma
17. In vivo evaluation of intravesical paclitaxel and combined bcl-xL antisense oligodeoxynucleotide treatment for orthotopic urothelial carcinoma
18. MORE EXTENSIVE LYMPHADENECTOMY IMPROVES OUTCOMES OF RADICAL CYSTECTOMY FOR BLADDER CANCER IN A NATIONWIDE MULTICENTER EVALUATION: 342
19. Lymphangiogenesis occurs in upper tract urothelial carcinoma and correlates with lymphatic tumour dissemination and poor prognosis
20. MORE EXTENSIVE LYMPHADENECTOMY IMPROVES OUTCOMES OF RADICAL CYSTECTOMY FOR BLADDER CANCER IN A NATIONWIDE MULTICENTER EVALUATION: 342
21. Long-Term Health-Related Quality-of-Life Outcomes after Permanent Prostate Brachytherapy
22. TOPICAL CHEMOTHERAPY FOR HUMAN NON-MUSCLE- INVASIVE UROTHELIAL CARCINOMA EXPLANTS: A REPRESENTATIVE TRANSLATIONAL TOOL FOR THE PRECLINICAL EVALUATION OF EXPERIMENTAL INTRAVESICAL THERAPIES: 1085
23. The role of the lymphatic system and its specific growth factor, vascular endothelial growth factor C, for lymphogenic metastasis in prostate cancer
24. Intravesical mitomycin C for superficial transitional cell carcinoma
25. Validation of computer-based training in ureterorenoscopy
26. Simple models improve the discrimination of prostate cancers from the peripheral gland by T1-weighted dynamic MRI
27. Impact of holmium:YAG and neodymium:YAG lasers on the efficacy of DNA delivery in transitional cell carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.